Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research.
Tse K, Sangodkar S, Bloch L, Arntsen K, Bae SC, Bruce IN, Connolly-Strong E, Costenbader KH, Dickerson B, Dörner T, Evans S, Kalunian K, Kao AH, Manzi S, Morand EF, Raymond SC, Rovin BH, Schanberg LE, Von Feldt JM, Werth VP, Williams Derricott A, Zook D, Franson T, Getz K, Peña Y, Hanrahan LM; ALPHA Project Global Advisory Committee. Tse K, et al. Among authors: connolly strong e. Lupus Sci Med. 2021 Feb;8(1):e000433. doi: 10.1136/lupus-2020-000433. Lupus Sci Med. 2021. PMID: 33563729 Free PMC article.
Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility.
Arnell C, Bergman M, Basu D, Kenney JT, Withers JB, Logan J, Harashima JL, Connolly-Strong E. Arnell C, et al. Among authors: connolly strong e. J Manag Care Spec Pharm. 2021 Dec;27(12):1734-1742. doi: 10.18553/jmcp.2021.21120. Epub 2021 Oct 20. J Manag Care Spec Pharm. 2021. PMID: 34669487 Free PMC article.
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.
Cohen S, Wells AF, Curtis JR, Dhar R, Mellors T, Zhang L, Withers JB, Jones A, Ghiassian SD, Wang M, Connolly-Strong E, Rapisardo S, Gatalica Z, Pappas DA, Kremer JM, Saleh A, Akmaev VR. Cohen S, et al. Among authors: connolly strong e. Rheumatol Ther. 2021 Sep;8(3):1159-1176. doi: 10.1007/s40744-021-00330-y. Epub 2021 Jun 19. Rheumatol Ther. 2021. PMID: 34148193 Free PMC article.
A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.
Cohen S, Akmaev VR, Withers JB, Connolly-Strong E. Cohen S, et al. Among authors: connolly strong e. Rheumatol Ther. 2022 Feb;9(1):309-311. doi: 10.1007/s40744-021-00387-9. Epub 2021 Nov 10. Rheumatol Ther. 2022. PMID: 34757533 Free PMC article. No abstract available.
16 results